We have located links that may give you full text access.
Journal Article
Review
The Potential Involvement of Glycocalyx Disruption in Abdominal Aortic Aneurysm Pathogenesis.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology 2024 March 8
BACKGROUND: Abdominal aortic aneurysm (AAA) is a weakening and expansion of the abdominal aorta. Currently, there is no drug treatment to limit AAA growth. The glycocalyx (GC) is the outermost layer of the cell surface, mainly composed of glycosaminoglycans (GAGs) and proteoglycans.
OBJECTIVE: The aim of this review was to identify a potential relationship between GC disruption and AAA pathogenesis.
METHODS: A narrative review of relevant published research was conducted.
RESULTS: GC disruption has been reported to enhance vascular permeability, impair immune responses, dysregulate endothelial function, promote extracellular matrix remodeling and modulate mechanotransduction. All these effects are implicated in AAA pathogenesis. GC disruption promotes inflammation through exposure of adhesion molecules and release of proinflammatory mediators. GC disruption affects how the endothelium responds to shear stress by reducing nitric oxide availabilty and adversely affecting the storage and release of several antioxidants, growth factors and antithromotic proteins. These changes exacerbate oxidative stress, stimulate vascular smooth muscle cell dysfunction and promote thrombosis, all effects implicated in AAA pathogenesis. Deficiency of key component of the GC, such as syndecan-4, were reported to promote aneurysm formation and rupture in the angiotensin-II and calcium chloride induced mouse models of AAA.
CONCLUSION: This review provides a summary of past research which suggests that GC disruption may play a role in AAA pathogenesis. Further research is needed to establish a causal link between GC disruption and AAA development.
OBJECTIVE: The aim of this review was to identify a potential relationship between GC disruption and AAA pathogenesis.
METHODS: A narrative review of relevant published research was conducted.
RESULTS: GC disruption has been reported to enhance vascular permeability, impair immune responses, dysregulate endothelial function, promote extracellular matrix remodeling and modulate mechanotransduction. All these effects are implicated in AAA pathogenesis. GC disruption promotes inflammation through exposure of adhesion molecules and release of proinflammatory mediators. GC disruption affects how the endothelium responds to shear stress by reducing nitric oxide availabilty and adversely affecting the storage and release of several antioxidants, growth factors and antithromotic proteins. These changes exacerbate oxidative stress, stimulate vascular smooth muscle cell dysfunction and promote thrombosis, all effects implicated in AAA pathogenesis. Deficiency of key component of the GC, such as syndecan-4, were reported to promote aneurysm formation and rupture in the angiotensin-II and calcium chloride induced mouse models of AAA.
CONCLUSION: This review provides a summary of past research which suggests that GC disruption may play a role in AAA pathogenesis. Further research is needed to establish a causal link between GC disruption and AAA development.
Full text links
Related Resources
Trending Papers
Demystifying normal-anion-gap metabolic acidosis: pathophysiology, aetiology, evaluation and diagnosis.Internal Medicine Journal 2024 July
Point-of-care ultrasound in Gastroenterology and Hepatology.Clinical Gastroenterology and Hepatology 2025 January 8
Nutritional Support in the ICU.BMJ : British Medical Journal 2025 January 2
Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association.Anaesthesia 2025 January 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app